0001746726-19-000001.txt : 20191104 0001746726-19-000001.hdr.sgml : 20191104 20191104115525 ACCESSION NUMBER: 0001746726-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191104 DATE AS OF CHANGE: 20191104 EFFECTIVENESS DATE: 20191104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Virion Therapeutics, LLC CENTRAL INDEX KEY: 0001746726 IRS NUMBER: 274966374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-352490 FILM NUMBER: 191188790 BUSINESS ADDRESS: STREET 1: 7 CREEK BEND COURT CITY: NEWARK STATE: DE ZIP: 19711 BUSINESS PHONE: 800-841-9303 MAIL ADDRESS: STREET 1: 7 CREEK BEND COURT CITY: NEWARK STATE: DE ZIP: 19711 D 1 primary_doc.xml X0708 D LIVE 0001746726 Virion Therapeutics, LLC 7 CREEK BEND COURT NEWARK DE DELAWARE 19711 800-841-9303 DELAWARE None None Limited Liability Company true 2018 Bernard Rudnick 7 Creek Bend Court Newark DE DELAWARE 19711 Executive Officer Director Andrew Luber 7 Creek Bend Court Newark DE DELAWARE 19711 Executive Officer Director Biotechnology No Revenues 06b false 2019-10-28 false true false 25000 6000000 250000 5750000 false 4 0 0 0 true false Virion Therapeutics, LLC /s/Bernard Rudnick Bernard Rudnick CEO 2019-11-04